| 12202836 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Seungil Han, David Hepworth, Frank Eldridge Lovering +18 more |
2025-01-21 |
|
| 11702424 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Seungil Han, David Hepworth, Frank Eldridge Lovering +18 more |
2023-07-18 |
$390,606,000 |
| 10793579 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Seungil Han, David Hepworth, Frank Eldridge Lovering +18 more |
2020-10-06 |
$629,973,000 |
| 10329302 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Seungil Han, David Hepworth, Frank Eldridge Lovering +18 more |
2019-06-25 |
$317,230,000 |
| 9879022 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Seungil Han, David Hepworth, Frank Eldridge Lovering +18 more |
2018-01-30 |
$267,454,000 |
| 9458168 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Seungil Han, David Hepworth, Frank Eldridge Lovering +15 more |
2016-10-04 |
$808,860,000 |
| 8916593 |
Alkoxy-substituted 2-aminopyridines as ALK inhibitors |
Andrew Cook, Jingrong Jean Cui, Kevin Dack, Judith Gail Deal, Danlin Gu +6 more |
2014-12-23 |
$289,866,000 |
| 8013019 |
Sulfonamide derivatives for the treatment of diseases |
Alan Daniel Brown, Paul Alan Glossop, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more |
2011-09-06 |
$533,448,000 |
| 7767715 |
Sulfonamide derivatives for the treatment of diseases |
Alan Daniel Brown, Paul Alan Glossop, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more |
2010-08-03 |
$307,895,000 |
| 7629358 |
Compounds useful for the treatment of diseases |
Alan Daniel Brown, Charlotte Alice Louise Lane, Paul Alan Glossop, David Anthony Price, Russell Andrew Lewthwaite +2 more |
2009-12-08 |
$355,902,000 |
| 7547731 |
Formamide derivatives for the treatment of diseases |
Alan Daniel Brown, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite, Paul Alan Glossop, Kim James +1 more |
2009-06-16 |
$205,302,000 |
| 7538141 |
Compounds for the treatment of diseases |
Alan Daniel Brown, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite, Paul Alan Glossop, Kim James +1 more |
2009-05-26 |
|
| 7528170 |
Sulfonamide derivatives for the treatment of diseases |
Alan Daniel Brown, Paul Alan Glossop, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more |
2009-05-05 |
$707,866,000 |
| 7268147 |
Compounds useful for the treatment of diseases |
Paul Alan Glossop, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite |
2007-09-11 |
$324,501,000 |
| 7244766 |
Sulfonamide derivatives for the treatment of diseases |
Alan Daniel Brown, Paul Alan Glossop, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite +3 more |
2007-07-17 |
$333,650,000 |
| 7241810 |
Formamide derivatives for the treatment of diseases |
Alan Daniel Brown, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite, Paul Alan Glossop, Kim James +1 more |
2007-07-10 |
$150,041,000 |
| 7183294 |
Indole derivatives useful for the treatment of diseases |
Alan Daniel Brown, Justin Stephen Bryans, Paul Alan Glossop, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite +1 more |
2007-02-27 |
$200,898,000 |
| 7176311 |
Process for preparing pharmaceutically active compounds |
Keith M. DeVries, Laurence James Harris, Philip Charles Levett, John Paul Mathias, Joanna Teresa Negri +2 more |
2007-02-13 |
$114,373,000 |
| 7138527 |
Indole derivatives useful for the treatment of diseases |
Alan Daniel Brown, Justin Stephen Bryans, Paul Alan Glossop, Charlotte Alice Louise Lane, Russell Andrew Lewthwaite +1 more |
2006-11-21 |
$296,227,000 |
| 7067660 |
Process for the preparation of pyrazolopyrimidinones |
Philip Charles Levett, Nicholas Murray Thomson |
2006-06-27 |
$116,377,000 |
| 7056934 |
Nicotinamide derivatives useful as PDE4 inhibitors |
John Paul Mathias |
2006-06-06 |
$125,956,000 |
| 6958402 |
3-(imidazolyl)-2-alkoxypropanoic acids |
Charlotte Moira Norfor Allerton, David John Bull, Robert John Maguire, John Steele |
2005-10-25 |
$229,343,000 |
| 6949577 |
Pharmaceuticals |
Charlotte Moira Norfor Allerton, Julian Blagg, John Steele |
2005-09-27 |
$119,913,000 |
| 6919457 |
3-(imidazolyl)-2-aminopropanoic acids |
Charlotte Moira Norfor Allerton, John Steele |
2005-07-19 |
$201,677,000 |
| 6916927 |
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
John Paul Mathias, Stephen Derek Albert Street, Anthony Wood |
2005-07-12 |
$283,397,000 |
